These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24049171)

  • 1. Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection.
    Fulton RB; Weiss KA; Pewe LL; Harty JT; Varga SM
    J Virol; 2013 Dec; 87(23):12694-700. PubMed ID: 24049171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.
    Dulek DE; Newcomb DC; Toki S; Goliniewska K; Cephus J; Reiss S; Bates JT; Crowe JE; Boyd KL; Moore ML; Zhou W; Peebles RS
    J Virol; 2014 Sep; 88(17):9655-72. PubMed ID: 24920804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.
    Olson MR; Hartwig SM; Varga SM
    J Immunol; 2008 Dec; 181(11):7958-68. PubMed ID: 19017987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection.
    Luangrath MA; Schmidt ME; Hartwig SM; Varga SM
    Immunohorizons; 2021 Feb; 5(2):59-69. PubMed ID: 33536235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
    Srikiatkhachorn A; Braciale TJ
    J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.
    Fulton RB; Meyerholz DK; Varga SM
    J Immunol; 2010 Aug; 185(4):2382-92. PubMed ID: 20639494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
    Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
    J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the breadth of the respiratory syncytial virus-specific T cell response.
    McDermott DS; Knudson CJ; Varga SM
    J Virol; 2014 Mar; 88(6):3135-43. PubMed ID: 24371055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.
    Moore ML; Chi MH; Goleniewska K; Durbin JE; Peebles RS
    Viral Immunol; 2008 Sep; 21(3):327-39. PubMed ID: 18788941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.
    De Baets S; Schepens B; Sedeyn K; Schotsaert M; Roose K; Bogaert P; Fiers W; Saelens X
    J Virol; 2013 Mar; 87(6):3314-23. PubMed ID: 23302879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection.
    Schmidt ME; Meyerholz DK; Varga SM
    Mucosal Immunol; 2020 May; 13(3):507-517. PubMed ID: 31844172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.
    Olson MR; Varga SM
    J Immunol; 2007 Oct; 179(8):5415-24. PubMed ID: 17911628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.
    Schmidt ME; Knudson CJ; Hartwig SM; Pewe LL; Meyerholz DK; Langlois RA; Harty JT; Varga SM
    PLoS Pathog; 2018 Jan; 14(1):e1006810. PubMed ID: 29293660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.
    Lee S; Mittler RS; Moore ML
    J Immunol; 2014 Jan; 192(1):293-9. PubMed ID: 24285837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
    Li H; Callahan C; Citron M; Wen Z; Touch S; Monslow MA; Cox KS; DiStefano DJ; Vora KA; Bett A; Espeseth A
    PLoS One; 2017; 12(11):e0187642. PubMed ID: 29121080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.
    Ostler T; Ehl S
    Eur J Immunol; 2002 Sep; 32(9):2562-9. PubMed ID: 12207340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.
    Eichinger KM; Kosanovich JL; Gidwani SV; Zomback A; Lipp MA; Perkins TN; Oury TD; Petrovsky N; Marshall CP; Yondola MA; Empey KM
    Front Immunol; 2020; 11():1673. PubMed ID: 32849580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection.
    Chang J; Choi SY; Jin HT; Sung YC; Braciale TJ
    J Immunol; 2004 Jan; 172(1):503-8. PubMed ID: 14688360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.